# Dexmedetomidine After Cardiac Surgery for Prevention of Delirium

> **NCT03477344** · PHASE3 · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 348 (actual)

## Conditions studied

- ICU Delirium

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Sodium chloride 0.9%

## Key facts

- **NCT ID:** NCT03477344
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-04
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-06-29
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2022-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03477344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03477344, "Dexmedetomidine After Cardiac Surgery for Prevention of Delirium". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03477344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*